中文名稱  酪氨酸激酶受體A抗體費(fèi)用 

英文名稱  Anti-TrkA

別    名 CIPA; CIPA; DKFZp781I14186; gp140trk; High affinity nerve growth factor receptor; High affinity nerve growth factor receptor precursor; High affinity nerve growth factor receptor precursor; MTC; MTC; neurotrophic tyrosine kinase receptor type 1; neurotrophic tyrosine kinase receptor type 1; Ntrk 1; Ntrk1; Ntrk1; NTRK1_HUMAN; Oncogene TRK; Oncogene TRK; p140 TrkA; p140-TrkA; TRK 1; Trk A; TRK; TRK; Trk-A; TRK1; TRK1 transforming tyrosine kinase protein; TRK1-transforming tyrosine kinase protein; Tropomyosin-related kinase A; Tyrosine kinase receptor A; Tyrosine kinase receptor; Tyrosine Receptor Kinase A.

產(chǎn)品屬性：

酪氨酸激酶受體A抗體費(fèi)用 濃    度  1mg/1ml

規(guī) 格  0.2ml/200μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Pig, Cow, Horse, Sheep

產(chǎn)品類型   一抗  

研究領(lǐng)域    

蛋白分子量  predicted molecular weight: 84kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from human TrkA

亞    型  IgG

純化方法   affinity purified by Protein A

儲 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

酪氨酸激酶受體A抗體費(fèi)用 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:100-500 ICC=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 The Trk family of nerve growth factor receptors includes Trk A(also referfed to as Trk A gp140),Trk B and Trk C. The prototype member of this gene family, Trk A, encodes a 140 kDa cell surface receptor , gp140, the expression of which is restricted in vivo to neurons of the sensory spinal and cranial gangliaof neurocrest origin. Nerve growth factor (NGF) stimulates tyrosine phosphorylation of Trk gp 140 in neural cell lines and in embryonic dorsal root ganglia. By comparison, BDNF and to a lesser extent, NT-3, but not NGF, can induce tyrosine phophorylayion of Trk B gp 145. The third member of the Trk receptor family, Trk C incodes a 140 kDa protein, Trk C gp140, that is preferentially expressed in brain tissue and primarily functions as a receptor for NT-3.An additional component of the Trk receptor complex, NGFR p175, binds to neurotrophic factors with low affinity but is required for efficient signaling. NGFR p175 accelerates Trk activation and may recruit downstream dffector molecules to the ligand-bound receptor complex.

Function : Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons. High affinity receptor for NGF which is its primary ligand, it can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axonal extension through NTRK1 but has no effect on neuron survival. Upon dimeric NGF ligand-binding, undergoes homodimerization, autophosphorylation and activation. Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades driving cell survival and differentiation. Through SHC1 and FRS2 activates a GRB2-Ras-MAPK cascade that regulates cell differentiation and survival. Through PLCG1 controls NF-Kappa-B activation and the transcription of genes involved in cell survival. Through SHC1 and SH2B1 controls a Ras-PI3 kinase-AKT1 signaling cascade that is also regulating survival. In absence of ligand and activation, may promote cell death, making the survival of neurons dependent on trophic factors.

Isoform TrkA-III is resistant to NGF, constitutively activates AKT1 and NF-kappa-B and is unable to activate the Ras-MAPK signaling cascade. Antagonizes the anti-proliferative NGF-NTRK1 signaling that promotes neuronal precursors differentiation. Isoform TrkA-III promotes angiogenesis and has oncogenic activity when overexpressed.

Subunit : Exists in a dynamic equilibrium between monomeric (low affinity) and dimeric (high affinity) structures. Homodimerization is induced by binding of a NGF dimer. Interacts with SQSTM1; bridges NTRK1 to NGFR. Forms a ternary complex with NGFR and KIDINS220; this complex is affected by the expression levels of KIDINS220 and an increase in KIDINS220 expression leads to a decreased association of NGFR and NTRK1 (By similarity). Interacts with SH2D1A; regulates NTRK1 (By similarity). Interacts (phosphorylated upon activation by NGF) with SHC1; mediates SHC1 phosphorylation and activation. Interacts (phosphorylated upon activation by NGF) with PLCG1; mediates PLCG1 phosphorylation and activation. Interacts (phosphorylated) with SH2B1 and SH2B2. Interacts with GRB2. Interacts with PIK3R1. Interacts with FRS2. Interacts with SORT1; may regulate NTRK1 anterograde axonal transport. Interacts with RAB7A.

Subcellular Location : Cell membrane; Single-pass type I membrane protein. Early endosome membrane; Single-pass type I membrane protein. Note=Internalized to endosomes upon binding of NGF or NTF3 and further transported to the cell body via a retrograde axonal transport.

Tissue Specificity : Isoform TrkA-I is found in most non-neuronal tissues. Isoform TrkA-II is primarily expressed in neuronal cells. TrkA-III is specifically expressed by pluripotent neural stem and neural crest progenitors.

Post-translational modifications : Ligand-mediated autophosphorylation. Interaction with SQSTM1 is phosphotyrosine-dependent. Autophosphorylation at Tyr-496 mediates interaction and phosphorylation of SHC1.

N-glycosylated (Probable). Isoform TrkA-I is N-glycosylated.

Ubiquitinated. Undergoes polyubiquitination upon activation; regulated by NGFR. Ubiquitination regulates the internalization of the receptor (By similarity)

DISEASE : Defects in NTRK1 are a cause of congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]. CIPA is characterized by a congenital insensitivity to pain, anhidrosis (absence of sweating), absence of reaction to noxious stimuli, self-mutilating behavior, and mental retardation. This rare autosomal recessive disorder is also known as congenital sensory neuropathy with anhidrosis or hereditary sensory and autonomic neuropathy type IV or familial dysautonomia type II.

Defects in NTRK1 are a cause of thyroid papillary carcinoma (TPC) [MIM:188550]. TPC is a common tumor of the thyroid that typically arises as an irregular, solid or cystic mass from otherwise normal thyroid tissue. Papillary carcinomas are malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. Note=Chromosomal aberrations involving NTRK1 are found in thyroid papillary carcinomas. Translocation t(1;3)(q21;q11) with TFG generates the TRKT3 (TRK-T3) transcript by fusing TFG to the 3'-end of NTRK1; a rearrangement with TPM3 generates the TRK transcript by fusing TPM3 to the 3'-end of NTRK1; an intrachromosomal rearrangement that links the protein kinase domain of NTRK1 to the 5'-end of the TPR gene forms the fusion protein TRK-T1. TRK-T1 is a 55 kDa protein reacting with antibodies against the C-terminus of the NTRK1 protein.

Similarity : Belongs to the protein kinase superfamily. Tyr protein kinase family. Insulin receptor subfamily.

Contains 2 Ig-like C2-type (immunoglobulin-like) domains.

Contains 2 LRR (leucine-rich) repeats.

Contains 1 LRRCT domain.

Contains 1 protein kinase domain.

Database links : UniProtKB/Swiss-Prot: P04629.4

實(shí)驗(yàn)流程：

全、新、優(yōu)、品、好四大特點(diǎn)：

酪氨酸激酶受體A抗體費(fèi)用 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊，產(chǎn)品一旦售出，實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。

技術(shù)外包服務(wù):

★酪氨酸激酶受體A抗體費(fèi)用 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測序、載體構(gòu)建等

★蛋白工程：原核、哺乳動物蛋白表達(dá)系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。

正在熱銷的相關(guān)產(chǎn)品：

Anti-phospho-Synapsin I (Ser553) /FITC 熒光素標(biāo)記磷酸化神經(jīng)突觸素1抗體IgGMulti-class antibodies規(guī)格： 0.2ml

HSP-70 peptide 熱休克蛋白-70(多肽抗原)Multi-class antibodies規(guī)格： 0.5mg

蛋白酪氨酸磷酸酶-1B/磷酸化酪氨酸抗體 Anti-PTP-1B/pTyr 0.1ml

Smad3 英文名稱： 細(xì)胞信號轉(zhuǎn)導(dǎo)分子SMAD3抗體 0.1ml

ENO1+ENO2+ENO3 英文名稱： 神經(jīng)元，肌肉特異性烯醇化酶抗體 0.2ml

Rhesus antibody Rh Phospho-MK6 (Ser207) 磷酸化原活化蛋白激酶MKK6抗體 規(guī)格 0.1ml

HSP-70 peptide 熱休克蛋白-70(多肽抗原)Multi-class antibodies規(guī)格： 0.5mg

Anti-RUNX1/AML1(phospho Ser249) /FITC 熒光素標(biāo)記兔抗人、大、小鼠磷酸化急性髓細(xì)胞1蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml

myelin P0 prothein( peripheral myelin prothein Zero;MPZ;MPP) 外周髓鞘蛋白0(P0蛋白)多肽抗原Multi-class antibodies規(guī)格： 0.5mg

金屬基質(zhì)硫蛋白抗體 anti-MT 0.1ml

Smad2 英文名稱： 細(xì)胞信號轉(zhuǎn)導(dǎo)分子Smad-2抗體 0.1ml

FKBP51 英文名稱： 類固醇受體復(fù)合物蛋白FKBP5抗體 0.2ml

Rhesus antibody Rh phospho-PFKL (Ser775) 磷酸化6磷酸果糖激酶抗體 規(guī)格 0.1ml

myelin P0 prothein( peripheral myelin prothein Zero;MPZ;MPP) 外周髓鞘蛋白0(P0蛋白)多肽抗原Multi-class antibodies規(guī)格： 0.5mg

FN 人纖維連結(jié)蛋白Multi-class antibodies規(guī)格： 48T

Anti-DBC1 缺失基因1Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh Netrin G1 ligand 軸突生長誘向因子G1配體抗體 規(guī)格 0.2ml

Human Glucose dependent insulin releasing polypeptide,GIP ELISA Kit 人葡萄糖依賴性釋放多肽 96T

Tyrosinase 英文名稱： 酪酸酶抗體 0.1ml

CD160/By55 英文名稱： NK細(xì)胞受體BY55抗體 0.2ml

Anti-DBC1 缺失基因1Multi-class antibodies規(guī)格： 0.2ml

IL34 Protein Mouse 重組小鼠 IL-34 蛋白 (His 標(biāo)簽)

木瓜蛋白酶(含100mL酶解緩沖液) 10mL

VCL Others Human 人 VCL / Vinculin 人細(xì)胞裂解液 (陽性對照)

BEL-7402人細(xì)胞 BEL-7402 human hepatocarcinoma cells 1640+10% FBS

雪羊皮膚細(xì)胞;SSHS1

人肺微內(nèi)皮細(xì)胞 (HPMEC)( 5×105 ) rRTEC, 大鼠腎小管上皮細(xì)胞 Rattus

CM-H049人直腸平滑肌細(xì)胞完全培養(yǎng)基100mL

ACVRL1 Others Cynomolgus 食蟹猴 ALK-1 / ACVRL1 人細(xì)胞裂解液 (陽性對照)

人星形膠質(zhì)細(xì)胞HA

HL60細(xì)胞，人原髓細(xì)胞細(xì)胞 大鼠細(xì)胞,IR983F細(xì)胞 角質(zhì)細(xì)胞培養(yǎng)基KM

MDA-MB-436(人癌細(xì)胞) 5×106cells/瓶×2

AsPC-1(人*癌細(xì)胞) 5×106cells/瓶×2 CM-R091大鼠成骨細(xì)胞完全培養(yǎng)基100mL EB病毒轉(zhuǎn)化的人B淋巴細(xì)胞;KM0501

酪氨酸激酶受體A抗體費(fèi)用 IL34 Protein Mouse 重組小鼠 IL-34 蛋白 (His 標(biāo)簽)

木瓜蛋白酶(含100mL酶解緩沖液) 10mL

VCL Others Human 人 VCL / Vinculin 人細(xì)胞裂解液 (陽性對照)

BEL-7402人細(xì)胞 BEL-7402 human hepatocarcinoma cells 1640+10% FBS

雪羊皮膚細(xì)胞;SSHS1

人肺微內(nèi)皮細(xì)胞 (HPMEC)( 5×105 ) rRTEC, 大鼠腎小管上皮細(xì)胞 Rattus